Neuroendocrine Tumor Treatment

Penn Medicine offers one of the only dedicated neuroendocrine tumor (NET) programs in the country with the combined expertise to treat both gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and pheochromocytomas and paragangliomas (PHEOs). Our program is the first and only one of its kind in the region.

Following the diagnosis and staging of neuroendocrine tumors, our cancer specialists at Penn Medicine's Abramson Cancer Center develop a personalized treatment plan that's right for you.

Treatment for neuroendocrine tumors include:

  • Surgery
    • Local and local-regional excision
    • Debulking surgery, including liver resection
  • Radiofrequency ablation
  • Liver transplantation
  • Laparoscopic cortical sparing surgery
  • Chemotherapy and biologic therapies
    • Hormone therapy
    • Octreotide
  • Proton pump inhibitors (PPIs)
  • Liver-directed therapies
  • Ethanol injection
  • Chemoembolization of the hepatic artery
  • Targeted therapy
  • External-beam Radiation Therapy
  • Radionuclide targeted therapies
  • Pre-operative alpha blockade
  • Management of symptoms related to catecholamine excess
  • Genetic testing and counseling
  • Integrative oncology services
  • Palliative care
  • Penn Home Care and Hospice
  • Clinical trials

Understanding a cancer diagnosis and treatment options can be difficult. If you would like to speak with a cancer nurse about a diagnosis, please call 800-789-7366 (PENN).